Israel Begins Clinical Trials of COVID-19 Vaccine

November 4, 2020

Israel Begins Clinical Trials of COVID-19 Vaccine

Israel will begin testing its BriLife vaccine, which was developed at Israel Institute for Biological Research on healthy volunteers as soon as early November. “Our final goal is 15 million doses for the residents of the State of Israel and for our close neighbors,” said Prof. Shmuel Shapira, director of the IIBR. Yourway operates a local depot with 7,5000 sq ft of capacity in Tel Aviv, to easily service Israel and the Mid-East region.

Back to Index

Stay Connected

Want to stay informed about the latest news, updates, and opportunities at Yourway?

Join our newsletter mailing list to never miss an update!

Media

Upcoming Events

SCOPE Supply Chain & Logistics Leadership Summit

February 2-5, 2026
Orlando, Florida

Schedule a Meeting

Global Clinical Supplies Group Asia Pacific Conference

March 11-13, 2026
Conrad Seoul Hotel, South Korea

Schedule a Meeting

Media

Articles

Just-in-Time or Plan Ahead? Mastering Logistics Strategies for Complex Clinical Trials

Open chat

Hello! How can I help you?